| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.97B | 30.33B | 28.59B | 28.26B | 25.23B | 22.76B |
| Gross Profit | 10.51B | 9.87B | 8.71B | 8.19B | 8.22B | 8.07B |
| EBITDA | 3.61B | 3.62B | 3.43B | 2.48B | 2.95B | 3.18B |
| Net Income | 2.17B | 1.85B | 1.67B | 1.22B | 1.50B | 1.63B |
Balance Sheet | ||||||
| Total Assets | 23.12B | 23.38B | 22.13B | 21.78B | 22.07B | 22.10B |
| Cash, Cash Equivalents and Short-Term Investments | 5.57B | 5.08B | 4.11B | 4.14B | 3.54B | 2.97B |
| Total Debt | 2.25B | 290.00M | 1.08B | 869.50M | 149.72M | 532.39M |
| Total Liabilities | 10.28B | 9.98B | 8.75B | 8.60B | 8.30B | 8.22B |
| Stockholders Equity | 12.84B | 13.40B | 13.38B | 13.18B | 13.77B | 13.89B |
Cash Flow | ||||||
| Free Cash Flow | 2.86B | 3.68B | 2.09B | 990.85M | 2.04B | 2.90B |
| Operating Cash Flow | 3.76B | 4.37B | 3.05B | 1.43B | 2.42B | 3.22B |
| Investing Cash Flow | -2.44B | -2.00B | -946.97M | -416.77M | -579.88M | -1.70B |
| Financing Cash Flow | -1.43B | -2.70B | -1.28B | -1.19B | -2.04B | -2.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $3.80B | 13.03 | 25.18% | 5.14% | 18.92% | 34.03% | |
74 Outperform | $4.86B | 16.08 | 16.18% | 3.95% | -2.81% | -2.66% | |
74 Outperform | $3.08B | 46.81 | 24.02% | ― | 23.12% | 16.20% | |
71 Outperform | $4.61B | 15.31 | 17.10% | 5.88% | 8.60% | 23.61% | |
70 Outperform | $3.23B | 17.91 | 45.84% | ― | 0.46% | 0.91% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
54 Neutral | $195.76M | ― | -23.12% | ― | 6.17% | 41.09% |